Pregnancies in Women Taking Accutane Continue, Despite Warnings
The drug label currently includes a strong recommendation for physicians to
obtain a patient's informed consent before being prescribed the drug. This
means that the patient understands the risks involved in taking the medication
-- a measure usually reserved for patients undergoing surgery or who are
involved in experimental trials. But in terms of addressing preventable
pregnancies, neither the FDA nor Hoffmann La-Roche could or would say whether
any additional steps will be taken to stem this problem.
In the meantime, the CDC will continue to work closely with the FDA to make
sure that physicians and patients are aware of the danger, Honein tells WebMD.
"It is too easy for this problem to slip out of everybody's mind," she
says, "but I hope this experience teaches everyone to be more
- Physicians and patients need to do a better job of following warnings on
drug labels, according to a CDC study.
- Pregnant women continue to be exposed to Accutane, a well-known teratogen,
11 years after the inception of a pregnancy prevention program for women taking
- The label for Accutane strongly recommends that physicians obtain a
patient's informed consent and encourage monthly visits to the